Imunon, Inc. (LON: 0HUZ)
London
· Delayed Price · Currency is GBP · Price in USD 0.875
-0.009 (-1.01%)
Jan 22, 2025, 2:35 PM BST
Imunon Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | - | - | 0.5 | 0.5 | 0.5 | 0.5 | Upgrade
|
| Cost of Revenue | 1.67 | - | - | 10.62 | 11.34 | 13.07 | Upgrade
|
| Gross Profit | -1.67 | - | 0.5 | -10.12 | -10.84 | -12.57 | Upgrade
|
| Selling, General & Admin | 7.99 | 9.74 | 13.69 | 10.89 | 7.64 | 8 | Upgrade
|
| Research & Development | 11.29 | 11.29 | 11.73 | - | - | - | Upgrade
|
| Operating Expenses | 19.28 | 21.03 | 25.42 | 10.89 | 7.64 | 8 | Upgrade
|
| Operating Income | -20.95 | -21.03 | -24.92 | -21.01 | -18.49 | -20.57 | Upgrade
|
| Interest Expense | - | -0.2 | -5.03 | -0.57 | -1.29 | -1.39 | Upgrade
|
| Interest & Investment Income | 0.62 | 1.16 | 0.45 | 0.01 | 0.12 | 0.5 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.4 | -0.4 | 0 | 0 | 0 | 0 | Upgrade
|
| EBT Excluding Unusual Items | -20.73 | -20.47 | -29.5 | -21.56 | -19.66 | -21.46 | Upgrade
|
| Impairment of Goodwill | - | - | - | -1.98 | - | - | Upgrade
|
| Other Unusual Items | - | -0.33 | 5.4 | 1.39 | -1.3 | 2.79 | Upgrade
|
| Pretax Income | -20.73 | -20.8 | -37.47 | -22.15 | -23.33 | -18.67 | Upgrade
|
| Income Tax Expense | -1.28 | -1.28 | -1.57 | -1.38 | -1.85 | -1.82 | Upgrade
|
| Net Income | -19.45 | -19.51 | -35.9 | -20.77 | -21.48 | -16.85 | Upgrade
|
| Net Income to Common | -19.45 | -19.51 | -35.9 | -20.77 | -21.48 | -16.85 | Upgrade
|
| Shares Outstanding (Basic) | 10 | 9 | 7 | 5 | 2 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 10 | 9 | 7 | 5 | 2 | 1 | Upgrade
|
| Shares Change (YoY) | 15.30% | 26.63% | 31.62% | 154.70% | 46.39% | 24.17% | Upgrade
|
| EPS (Basic) | -1.90 | -2.16 | -5.03 | -3.83 | -10.08 | -11.58 | Upgrade
|
| EPS (Diluted) | -1.90 | -2.16 | -5.03 | -3.83 | -10.08 | -11.58 | Upgrade
|
| Free Cash Flow | -18.22 | -19.47 | -23.36 | -16.54 | -15.64 | -20.61 | Upgrade
|
| Free Cash Flow Per Share | -1.78 | -2.15 | -3.27 | -3.05 | -7.34 | -14.16 | Upgrade
|
| Gross Margin | - | - | 100.00% | - | - | - | Upgrade
|
| Operating Margin | - | - | -4984.31% | -4201.44% | -3697.28% | -4113.09% | Upgrade
|
| Profit Margin | - | - | -7179.65% | -4153.85% | -4296.71% | -3370.31% | Upgrade
|
| Free Cash Flow Margin | - | - | -4672.94% | -3307.04% | -3127.55% | -4121.63% | Upgrade
|
| EBITDA | -20.68 | -20.78 | -24.73 | -20.3 | -17.74 | -19.84 | Upgrade
|
| D&A For EBITDA | 0.27 | 0.25 | 0.2 | 0.7 | 0.74 | 0.72 | Upgrade
|
| EBIT | -20.95 | -21.03 | -24.92 | -21.01 | -18.49 | -20.57 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.